title: Moderate consumption of red wine (cabernet sauvignon) improves ischemia-induced neovascularization in ApoE-deficient mice: effect on endothelial progenitor cells and nitric oxide.
abstract: Moderate consumption of red wine is associated with a decreased incidence of cardiovascular diseases in populations with relatively high amount of fat in the diet. However, the mechanisms involved in this protective effect are not completely understood. Here we show that moderate consumption of red wine (equivalent to 2 glasses/day in humans) but not ethanol only, improves blood flow recovery by 32% after hindlimb ischemia in hypercholesterolemic ApoE-deficient mice. In ischemic tissues, red wine consumption reduces oxidative stress and increases capillary density by 46%. Endothelial progenitor cells (EPCs) have been shown to have an important role in postnatal neovascularization. We found that the number of EPCs is increased by 60% in ApoE mice exposed to red wine. Moreover, the migratory capacity of EPCs is significantly improved in red wine-drinking mice. The wine used in our study is a cabernet sauvignon from Languedoc-Roussillon, France, which contains a relatively high concentration (4-6 mg/L) of the polyphenolic antioxidant resveratrol. We demonstrate that resveratrol can rescue oxidized low-density lipoprotein (oxLDL)-induced impairment of in vitro angiogenic activities in human umbilical vein endothelial cells (HUVECs). Resveratrol exposure is also associated with increased activation of Akt/eNOS together with a restoration of nitric oxide production in HUVECs exposed to oxLDL. Our study suggests that moderate consumption of red wine improves ischemia-induced neovascularization in high-cholesterol conditions by increasing the number and the functional activities of EPCs and by restoring the Akt-eNOS-NO pathway.
authors.affiliation: Department of Cardiovascular Research, Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke Est, Montreal, QC, H2L 4M1 Canada.
authors.forename: Jonas
authors.initials: J
authors.lastname: Lefèvre
authors.forename: Sophie-Elise
authors.initials: SE
authors.lastname: Michaud
authors.forename: Paola
authors.initials: P
authors.lastname: Haddad
authors.forename: Sylvie
authors.initials: S
authors.lastname: Dussault
authors.forename: Catherine
authors.initials: C
authors.lastname: Ménard
authors.forename: Jessika
authors.initials: J
authors.lastname: Groleau
authors.forename: Julie
authors.initials: J
authors.lastname: Turgeon
authors.forename: Alain
authors.initials: A
authors.lastname: Rivard
mesh_terms: D053687:Adult Stem Cells / Q000166:cytology / Q000378:metabolism / Q000473:pathology*; D000818:Animals; D001057:Apolipoproteins E / Q000172:deficiency* / Q000235:genetics; D002465:Cell Movement / Q000235:genetics; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism / Q000473:pathology*; D006614:Hindlimb / Q000098:blood supply; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000235:genetics / Q000503:physiopathology; D007511:Ischemia / Q000150:complications* / Q000503:physiopathology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000209:etiology* / Q000235:genetics / Q000503:physiopathology; D009569:Nitric Oxide / Q000378:metabolism / Q000502:physiology*; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology; D014920:Wine
chemical_list: D001057:Apolipoproteins E; D013267:Stilbenes; D009569:Nitric Oxide; D000077185:Resveratrol